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Background. We hypothesized that endotoxin (LPS) would
impair bradykinin (BK)-induced calcium (Ca21) mobilization in
aortic endothelial cells, perhaps due to cytotoxicity or via stimu-
lation of nitric oxide (NO) synthesis. As well, we sought to define
contributions of LPS-stimulated Ca21 mobilization to these ef-
fects.
Methods. LPS- or BK-induced increments of intracellular Ca21
were assessed by microspectrofluorimetry with fura-2 in passaged
bovine aortic endothelial cells. Time- and dose-dependent effects
of LPS exposure (6 inhibitors of NO or prostaglandin synthesis)
on subsequent BK-induced Ca21 mobilization and on attached
cell counts were determined.
Results. LPS (0.1 to 1.0 mg/ml) led to rapid increments of Ca21,
while Ca21 responses were delayed following LPS (1 to 10 mg/ml)
and lower doses were without effect. By contrast, LPS more
potently (1.0 pg to 1.0 mg/ml) led to dose- and time-dependent
impairment of subsequent BK-induced Ca21 mobilization, with
peak effect at four to six hours, persisting for at least 18 hours.
This delayed effect on BK-response was unaltered by inhibition of
either NO synthase or cyclooxygenase. The effect of LPS on
BK-responsivity depended importantly on cell confluence, as it
was not observed in subconfluent cells. By contrast, LPS-induced
cell detachment, which was observed only at doses $ 1.0 mg/ml,
did not depend on confluence.
Conclusions. Different mechanisms lead to endothelial cytotox-
icity and to impaired BK-response following LPS. Only the former
effect, occurring at higher doses, might depend on initial LPS-
induced Ca21 mobilization.
Septic shock is often characterized by vasoconstrictor-
resistant systemic vasodilation, as well as by failure of
multiple organ systems. The contractile defect appears due,
in part, to induction of nitric oxide (NO) synthesis by
bacterial endotoxin (lipopolysaccharide, LPS) and, per-
haps, by inflammatory cytokines [1, 2]. As well, LPS may
impair vascular contraction by NO independent mecha-
nisms [3]. We and others have suggested that widespread
endothelial dysfunction may contribute to LPS-induced
organ failure, perhaps by interfering with regulation of
blood flow distribution, by favoring a procoagulant pheno-
type, or by leading to localized vasospasm [4, 5]. Indeed,
LPS acts directly on intact arteries or cultured cells to
impair endothelium-dependent relaxation and agonist
stimulated NO release [6]. Similar findings in cultured
endothelial cell suspensions have implicated impaired ag-
onist-induced Ca21 mobilization as the likely explanation
for decreased NO synthesis [7]. An opposing literature
suggests that LPS may lead to immediate increments of
endothelial NO synthesis (via activation of a calcium-
sensitive NO synthase), while others have called attention
to the endothelial cytotoxicity that results from exposure to
LPS or inflammatory cytokines in vitro [8, 9].
We hypothesized that LPS would impair agonist-induced
Ca21 mobilization, perhaps due to cell injury or consequent
to increased NO synthesis. As well, we sought to define
direct effects of LPS on endothelial Ca21, to understand
how these might contribute to subsequent cytotoxicity or
impaired vasodilation. Experiments focused, therefore, on
definition of both dose-response and time-action curves for
the effect of LPS on bradykinin (BK)-induced Ca21 mobi-
lization, on use of selective inhibitors to assess possible
contributions of NO or prostanoids to this effect, and on
comparison of the dose-response curves for the Ca21-
mobilization defect with those for direct effects of LPS on
endothelial Ca21 or for LPS-induced endothelial cytotox-
icity.
METHODS
Reagents
Escherichia coli LPS (E. coli strain 055:B5) was obtained
from Difco (Detroit, MI, USA); fetal bovine serum (FBS)
from HyClone (Logan, UT, USA); fura-2 AM and Ca21
standards were from Molecular Probes (Eugene, OR,
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USA); and all other chemicals were obtained from Sigma
Chemicals (St. Louis, MO, USA).
Isolation and culture of bovine aortic endothelial cells.
Segments of bovine thoracic aorta (.20 cm long) were
obtained fresh from an abattoir and transported to the
laboratory in HEPES buffered saline (HBS, 130 mM NaCl,
5 mM KCl, 1 mM CaCl2, 1 mM MgSO4, 10 mM HEPES, 10
mM dextrose, pH 7.4) supplemented with penicillin (50
U/ml), streptomycin (50 mg/ml), amphotericin B (125 ng/
ml), and nystatin (250 U/ml). Each aortic segment was
stripped of adventitia, rinsed in fresh buffer, opened lon-
gitudinally, rinsed again, then incubated with 0.2% colla-
genase (Type IA) for 30 minutes. Endothelial cells were
scraped off with a teflon spatula, washed in HBS and
transferred to a vented plastic culture flask (T25, Falcon;
Becton-Dickenson, Lincoln Park, NJ, USA). Cells were
cultured in medium 199, supplemented with 100 U/ml
penicillin G, 0.1 mg/ml streptomycin, and 20% FBS; they
were then grown at 37°C in a 5% CO2 environment. Cells
were identified as endothelial in all experiments by their
characteristic morphology on phase-contrast microscopy
and by exhibiting dose-dependent BK-induced Ca21 mobi-
lization; identity in some wells was further confirmed by
staining for Factor VIII antigen or by uptake of acylated
LDL. Medium was changed every 72 hours and cells were
passaged every five to seven days, then used for experi-
ments three days after reaching confluence, unless noted
otherwise. Prior to experiments, cells were detached using
trypsin (0.5 g porcine trypsin/liter)/EDTA (0.2 g/liter) and
seeded into either 24-well Falcon plastic culture clusters for
cell counts or 8-well Lab-Tek® chambered coverglass slides
(Nunc, Naperville, IL, USA) for measurement of Ca21. All
experiments were performed between passages 5 and 10.
As responses did not differ significantly among the cells
from five separate isolations, or as a function of passage
number, data were pooled for each protocol.
Cell counting
Endothelial cells (;3 3 104/ml) were plated in 24-well
plastic culture clusters and grown either to confluence or
;80% of confluence. Confluent cells were allowed to
continue for three days post-confluence. For the 24 hours
prior to LPS exposure, cells were maintained either in
normal (20% FBS) medium, or in serum-deprived medium
(1% FBS). Following incubation with LPS, medium was
aspirated, cells were rinsed once with phosphate buffered
saline (PBS, 120 mM NaCl, 2.7 mM KCl, 10 mM phosphate
salts, pH 7.4), then trypsinized for three minutes at room
temperature. Previously adherent cells were then sus-
pended in fresh medium, washed, and counted using trypan
blue and a hemocytometer.
Measurement of intracellular Ca21
Following incubation with LPS (1 pg to 1 mg/ml, 1 to 18
hr), 6Nv-nitro-L-arginine methyl ester (L-NAME, 1.0
mM), 6 indomethacin (0.01 mM), cells were rinsed twice in
HBS with 0.1% bovine serum albumin. They were then
loaded with fura-2 AM, and transferred to the stage of an
inverted Nikon Diaphot® microscope that was coupled to a
microcomputer-controlled, photomultiplier-tube (PMT)-
based ratio spectrofluorimeter (Biomedical Instrumenta-
tion Group, University of Pennsylvania, Philadelphia, PA,
USA), as described previously [10, 11]; results were taken
from fields of 5 to 100 cells. Calcium concentration (nM)
was calculated as described previously [10, 11] by the
method of Grynkiewicz, Poenie and Tsien [12]. All Ca21
responses were acquired for 30 seconds to establish a
baseline and for $ 210 seconds to characterize peak and
plateau responses following either LPS or 25 mM BK. The
concentration of BK was chosen from preliminary dose-
response experiments as that resulting in maximal peak
Ca21 mobilization.
Statistical analysis
Data are expressed as group mean 6 SEM (SEM). N refers
to the number of wells studied in each group. Group
comparisons were by ANOVA with Bonferroni correction
for multiple comparisons; P values , 0.05 were considered
significant.
RESULTS
Bradykinin (BK) led to an immediate Ca21 mobilization,
followed by a sustained plateau above baseline (Fig. 1). The
peak effect of BK was inhibited in a dose- and time-
dependent manner by prior LPS exposure (Figs. 1 and 2).
Brief (one hr) exposure failed to alter BK responses
Fig. 1. Sample traces of endothelial [Ca21]i versus time following stim-
ulation with 25 mM bradykinin (BK). Preincubation with 1 mg/ml lipo-
polysaccharide (LPS) decreased peak response when compared with
vehicle-treated control.
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significantly. By contrast, after two hours, BK response was
impaired by 1 mg/mL LPS and, at four hours, LPS (1 pg/ml
to 1 mg/ml) led to dose-dependent inhibition of BK re-
sponse (Fig. 2). The effect of 1 mg/ml LPS was sustained
over prolonged (18 hr) exposure (Fig. 3).
Lipopolysaccharide (LPS; 1 pg/ml to 1 ng/ml) itself had
no direct effect on endothelial Ca21 (Fig. 4). Higher
concentrations (1 to 10 mg/ml) led to small and delayed
increments in Ca21. By contrast, only at (subsequently
cytotoxic) doses, significantly higher (0.1 to 1.0 mg/ml) than
those which impaired BK responsivity, did LPS lead to
immediate, albeit limited, endothelial Ca21 mobilization.
The ability of LPS to impair endothelial Ca21 mobiliza-
tion by BK depended importantly on cell confluence prior
to exposure. The effect was observed in cells which were
studied ;three days after reaching confluence, but not in
cells studied prior to (;80%) confluence (Fig. 3). Serum
deprivation (from 20% to 1% FBS) for 24 hours prior to
LPS exposure, in order to induce growth arrest, did not
mimic the effect of cell confluence on BK and LPS
response (Fig. 3). By contrast with effects on Ca21 re-
sponses, LPS-induced cytotoxicity (as assessed by a de-
crease in the number of adherent cells) appeared indepen-
dent of confluence. LPS was without effect on cell counts
prior to six hours incubation or at concentrations # 1 ng/ml
(N 5 12/group). LPS (1 mg/ml, 18 hr incubation) decreased
cell counts significantly in all groups (confluent/20% FBS,
236 6 3.5%; confluent/1% FBS, 266 6 3.3%; subconflu-
ent/20% FBS, 261 6 2.2%; subconfluent/1% FBS, 246 6
6.6%; N 5 12/group). Higher concentrations of LPS (0.1 to
1.0 mg/ml, N 5 6 to 12) led to widespread (.90%) cell
detachment at 18 hours. The effect on cell counts did not
Fig. 2. Dose-response and time-action data for effect of lipopolysaccharide (LPS) on subsequent bradykinin (BK)-induced Ca21 responses (N 5
12/dose and time). (A) No effect of one hour LPS exposure. (B) Significant decrease in BK response with two hours exposure to 1 mg/ml LPS. LPS
incubation for four hours (C) led to dose-dependent (1 pg to 1 mg/ml) decrements of BK response. Graded effects of LPS (1 ng to 1 mg/ml) were also
observed at six hours (D). Symbols are: (f) control; (F) 1 pg/ml; () 1 ng/ml; () 1 mg/ml.
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appear to differ significantly between 18 hours incubation
and a shorter, six hour LPS exposure (confluent/20% FBS
239 6 3.5%, N 5 12).
The effect of LPS on BK-induced Ca21 mobilization
appeared not to depend on induction of NO synthesis, as it
was unaffected by co-incubation with the NO synthase
inhibitor L-NAME (Fig. 5). Similarly, the LPS-induced
decrement in BK response was not ameliorated by co-
incubation with the cyclooxygenase inhibitor indomethacin
(Fig. 5).
DISCUSSION
We explored the dose-response and time-action charac-
teristics of LPS effects in cultured bovine aortic endothelial
cells, focusing on agonist-induced Ca21 mobilization and
cytotoxicity. High concentrations of LPS (.1 mg/ml) in-
creased endothelial Ca21 directly, albeit less than following
a maximal BK stimulus, and were associated with delayed
cytotoxicity as assessed by cell detachment. By contrast,
starting at 1 pg/ml, LPS led to time- and dose-dependent
impairment of subsequent BK-induced Ca21 mobilization.
This effect was not altered by inhibition of either NO or
prostaglandin biosynthesis. This latter effect on BK respon-
sivity, but not LPS-induced toxicity, depended critically on
culture conditions, in that it was only observed in confluent
cells. We speculate that LPS may impair agonist-induced
endothelium dependent relaxation by inhibiting endothelial
Ca21 mobilization in response to vasodilators. This effect
appears mechanistically distinct from those that may lead
to endothelial cytotoxicity, and depends neither on early
Fig. 3. Lipopolysaccharide (LPS; 1 mg/ml, 18 hr incubation, N 5 4 to 6/dose and treatment group) decreased bradykinin (BK)-induced Ca21
mobilization in confluent endothelial cells (A and B), whether cultured with 20% FBS (A) or previously quiesced with 1% FBS (B). By contrast, the effect
of LPS was significantly attenuated in subconfluent cells (C and D), even when quiesced with 1% FBS. Symbols are: (f) control; (F) 1 pg/ml; () 1
ng/ml; () 1 mg/ml.
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Ca21 mobilization by LPS nor on induction of NO synthe-
sis.
Organ failure in sepsis or experimental endotoxemia
could be mediated by direct parenchymal cytotoxicity [9,
13, 14] or by locally-ineffective delivery or utilization of
oxygen and nutrients. The latter may be manifest as
supply-dependent oxygen utilization and associated with
localized tissue hypoxia [15]. In addition, LPS administra-
tion can cause immediate hypotension, which is often
responsive to fluid resuscitation, but then, over hours leads
to progressive fluid and vasopressor-resistant hypotension
and systemic vasodilation [16]. We and others have sug-
gested that impaired vascular contraction may depend in
part on induction of vascular NO synthesis, while defective
endothelium-dependent vasodilation might contribute to
tissue hypoxia by interfering with the normally-exquisite
matching of perfusion with local metabolic demand [1, 4].
Indeed, LPS or a variety of inflammatory cytokines can
each interfere with vasoconstrictor responsivity in isolated
preparations both by NO-dependent and -independent
mechanisms, and can also inhibit both vasodilation or
stimulated NO synthesis in vascular preparations or in
cultured endothelial cells [1, 3, 6]. Further, there appears to
be extraordinary regional variability in the vascular re-
sponses to LPS, including observations of mesenteric and
renal vasoconstriction or hypoperfusion, even in the setting
of marked systemic vasodilation [17, 18].
Bradykinin, acetylcholine, and other endothelium-de-
pendent vasodilator agonists, act via G-protein-coupled
receptors to mobilize intracellular Ca21, leading to calm-
odulin-dependent activation of constitutive NO synthase
[19, 20]. This signal transduction system may also activate
other second messengers and stimulate the release of other
paracrine mediators, such as prostaglandins and hyperpo-
larizing vasodilator factors. While inflammatory cytokines
appear to down-regulate steady state NO synthase expres-
sion in cultured endothelial cells [21], decreased vasodila-
tor responses could also depend on inhibition of agonist-
stimulated Ca21 mobilization, leading to deficient EDRF
release. Impairment of agonist-induced Ca21 mobilization
by 18 to 24 hours exposure to LPS appears, in other studies,
to underlie the NO-independent component of impaired
mesangial cell or vascular myocyte responses [10, 11].
Likewise, an earlier report in endothelial cell suspensions
suggested such a mechanism [7]. We have now extended
these observations by demonstrating that LPS impairs
BK-induced Ca21 mobilization similarly in adherent endo-
thelial cells. The effect in endothelial cells occurs at LPS
doses three to six orders of magnitude lower than in
myocytes or mesangial cells, exhibits a delayed onset, and
peaks at four to six hours of LPS exposure. Our data do not
allow us to speculate whether the delayed onset or resolu-
tion of this response depend on new protein synthesis, or
whether the long duration of response following 1 mg/ml
LPS might be due to subtle cell damage. In this respect, it
is not surprising that responses to the highest dose of LPS
became apparent at an earlier time (2 hr) than responses to
lower doses and cell counts did not suggest any greater cell
loss at 18 hours than at six hours.
Based on the known ability of NO, acting via cGMP, to
favor Ca21 resequestration or efflux, and the ability of LPS
to induce expression of NO synthase, we had hypothesized
Fig. 4. Time course of endothelial [Ca21]i following graded doses of LPS
(1 pg to 1 mg/ml, N 5 4 to 16/dose). Low doses (1 pg to 1 ng/ml) failed to
increase Ca21 while higher doses (1 to 10 mg/ml) led to only delayed
increments of Ca21. Only the highest doses of LPS (0.1 to 1 mg/ml)
increased endothelial Ca21 within the first minute following drug addition.
Symbols are: (M) control; (E) 1 pg/ml LPS; () 1 ng/ml LPS; () 1 mg/ml
LPS; (X) 100 mg/ml; (*) 1 mg/ml LPS.
Fig. 5. Histograms showing decreased bradykinin (BK) response due to
18 hours incubation with 1 mg/ml lipopolysaccharide (LPS; N 5 8 to
12/group), without any amelioration of this effect by coincubation with 1.0
mM L-NAME (left bars). Likewise, coincubation with 10 mM indomethacin
failed to attenuate the effect of LPS (right bars).
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that NO might mediate the impairment of agonist-induced
Ca21 mobilization, at least following prolonged LPS expo-
sure. However, the effect of LPS on BK responses was not
at all ameliorated by incubation with a nonselective NO
synthase inhibitor, L-NAME, in concentrations sufficient to
block NO synthesis in a variety of LPS-exposed cells and
preserve contractile responses in endothelium-denuded
vessels from LPS-treated animals [1]. Similarly, co-incuba-
tion with indomethacin failed to preserve BK response,
arguing against a mechanism that depends on cyclooxygen-
ase induction, prostaglandin synthesis, and cAMP effect.
We therefore conclude that LPS acted more directly,
perhaps via a tyrosine kinase [22] or protein kinase C [23],
to alter Ca21 homeostasis or interfere with G protein
signaling [24]. Targets for such a signaling system could
include receptor proteins, perhaps leading to desensitiza-
tion, G protein subunits, or downstream elements regulat-
ing Ca21 release or resequestration. Our data do not allow
us to distinguish between these possibilities. However, since
LPS impaired endothelium-dependent relaxation by both
acetylcholine and substance P in aortic rings [1], limited
ADP-induced Ca21 mobilization in endothelial cell suspen-
sions [7] and thrombin-induced Ca21 mobilization in ad-
herent vascular myocytes [11], we favor mechanisms more
general than modification of the BK receptor.
Lipopolysaccharide acts directly on many cells to alter
function and, in some cases lead to cell death [9, 13, 14, 25].
These effects may be facilitated by serum factors, including
sCD14 or LPS binding protein [26], and may be amplified
or perpetuated by induction of inflammatory cytokines [5].
Direct mobilization of Ca21 by LPS could be a key step
leading to apoptotic cell death [13]. It could also explain
immediate NO synthesis and vasodilation, via activation of
constitutive NO synthase [8]. By contrast, Fleming, Dam-
bacher and Busse suggested that LPS leads to “immediate”
endothelial NO and prostacyclin synthesis, along with small
Ca21 increments, due to release of endothelium-derived
kinin, as all responses were blocked by a selective B2-
receptor antagonist [27].
We found dose-dependent endothelial Ca21 mobiliza-
tion by LPS, which was, however, only observed at concen-
trations $1 mg/ml, and was delayed by more than one
minute at concentrations ,100 mg/ml. These effects,
smaller in magnitude than those that followed BK stimu-
lation, were only observed at LPS doses far in excess of
those that were required to impair subsequent endothelial
BK responses. Likewise, the effects on endothelial viability,
as assessed by counts of adherent cells, and observation of
morphologic changes typical of programmed cell death,
were only observed at LPS doses $1 mg/ml. LPS-induced
cytotoxicity varies tremendously among different cell types.
Our results are in accord with results in other endothelial
cells, while even higher doses of LPS often fail to alter
viability in mesangial cells or vascular myocytes [10, 11]. It
remains unknown whether endothelial cells derived from
different vascular beds or from vessels of smaller caliber
would respond similarly. Collectively, these data lead us to
conclude that different mechanisms must mediate LPS-
stimulated Ca21 mobilization, with subsequent associated
cytotoxicity, and the ability of lower doses of LPS to
interfere with BK responses.
A second line of evidence favoring distinct mechanisms
for LPS impairment of BK response and LPS induced
cytotoxicity was the observation that the former depended
critically on endothelial confluence, while the latter did not.
This appears consistent with prior reports that other signal
transduction pathways are altered significantly by endothe-
lial confluence in culture [28–31]. Indeed, this might also
suggest that LPS could impair responses in endothelium-
intact vessels and raises the possibility that regenerating
endothelium might be less sensitive to such injury.
In conclusion, LPS directly mobilizes intracellular Ca21,
leads to delayed cytotoxicity, and impairs BK induced Ca21
mobilization in adherent cultured bovine endothelial cells.
The effect on BK response was not altered by inhibition of
either NO synthase or cyclooxygenase. Differences in dose-
response and time-action characteristics of these effects, as
well as differing sensitivity to culture conditions suggested
that distinct mechanisms lead to LPS-induced cytotoxicity
and to impaired BK responsivity. Further, the delayed
effects of LPS on cellular integrity might depend on initial
LPS-induced Ca21 responses, but the effects on subsequent
agonist responsivity do not. Finally, the high doses of LPS
required to lead to relatively smaller increments of endo-
thelial Ca21 than are usually observed following application
of endothelium-dependent vasodilators such as BK lead us
to doubt direct endothelial Ca21 mobilization as the sole
mechanism for early hypotension in LPS treated animals.
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APPENDIX
Abbreviations used in this article are: ADP, adenosine 59-diphosphate;
BK, bradykinin; EDRF, endothelium-derived relaxing factor; FBS, fetal
bovine serum; HBS, HEPES buffered saline; LDL, low density lipopro-
tein; L-NAME, Nv-nitro-L-arginine methyl ester; LPS, lipopolysaccha-
ride; NO, nitric oxide; PBS, phosphate buffered saline; PMT, photomul-
tiplier tube.
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